The effects of conjugated linoleic acid supplementation on the serum levels of Interleukin-6 and Sirtuin-1 in COPD patients

H. Ghobadi-Marallu (Ardabil, Islamic Republic of Iran), S. Matin (ArdabilArdabil, Islamic Republic of Iran), A. Nemati (ArdabilArdabilArdabil, Islamic Republic of Iran), M. Mesgari-Abbasi (TabrizArdabilArdabilArdabil, Islamic Republic of Iran), S. Ghorbani (ArdabilTabrizArdabilArdabilArdabil, Islamic Republic of Iran), M. Aslani (ArdabilArdabilTabrizArdabilArdabilArdabil, Islamic Republic of Iran)

Source: International Congress 2019 – Basic research of airway diseases
Session: Basic research of airway diseases
Session type: Oral Presentation
Number: 3582
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Ghobadi-Marallu (Ardabil, Islamic Republic of Iran), S. Matin (ArdabilArdabil, Islamic Republic of Iran), A. Nemati (ArdabilArdabilArdabil, Islamic Republic of Iran), M. Mesgari-Abbasi (TabrizArdabilArdabilArdabil, Islamic Republic of Iran), S. Ghorbani (ArdabilTabrizArdabilArdabilArdabil, Islamic Republic of Iran), M. Aslani (ArdabilArdabilTabrizArdabilArdabilArdabil, Islamic Republic of Iran). The effects of conjugated linoleic acid supplementation on the serum levels of Interleukin-6 and Sirtuin-1 in COPD patients. 3582

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum uric acid levels among COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 435s
Year: 2003

The effect of conjugated linoleic acid supplementation on the nutritional status of COPD patients
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


Serum uric acid levels among patients with COPD exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 33s
Year: 2006

Blood plasma levels of ascorbic acid in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 674s
Year: 2006

Effect of omega-3 and phosphoethanolamine in patients with asthma
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009


Effects of long-term supplementation of branched-chain amino acids on muscle metabolism in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 638s
Year: 2006

Association between Ω3 and Ω6 fatty acid dietary intakes and serum inflammatory markers in Spanish COPD patients
Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases
Year: 2010


Oral polyunsaturated fatty acid supplementation as adjuvant therapy for asthmatic children
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012

Serum levels of hyaluronic acid are associated with COPD severity and predict survival
Source: Eur Respir J, 53 (3) 1801183; 10.1183/13993003.01183-2018
Year: 2019



Assessment of serum uric acid in COPD exacerbations
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Supplementation with polyunsaturated fatty acids influence the inflammatory response and airway nitric oxide in patients with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008



Serum uric acid and uric acid/creatinine ratio in exacerbations of COPD
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011

Increase in plasma alpha-linolenic acid is positively associated with lung function. The emphysema and cancer action program (EMCAP) study
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008

Anti-inflammatory and cytoprotective actions of the endogenous docosahexaenoic acid (DHA) electrophilic derivative 17-oxo-DHA
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012

Differential actions of the endogenous docosahexaenoic acid (DHA) electrophilic derivative 17-oxo-DHA in macrophages and bronchial epithelial cells
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013

Urinary uric acid excretion and overnight change in the urinary uric acid: creatinin ratio as a marker of tissue hypoxia in patients with COPD and OSA
Source: Eur Respir J 2006; 28: Suppl. 50, 408s
Year: 2006

Effects of different serum theophylline concentrations on erythropoietin and hematocrit levels in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 422s
Year: 2003

Energy restriction and serum levels and secretion of cytokines in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 209s
Year: 2001

Serum ascorbid acid concentration in COPD patients with partial and with complete respiratory failure
Source: Eur Respir J 2001; 18: Suppl. 33, 209s
Year: 2001

Effect of intermittent hypoxia on the expression of fatty acid binding proteins in human adipocytes and macrophages
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011